Health

FDA approves a second Alzheimer’s drug that may modestly sluggish illness : NPR

Health

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s

Health

FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly

Health

Will MDMA’s FDA setback derail psychedelic drug analysis? : Photographs

Health

Alzheimer’s drug donanemab will get FDA advisory committee’s inexperienced gentle : Photographs

Health

FDA advisors reject MDMA as therapy for PTSD : Pictures

Health

FDA Panel Rejects Use of MDMA for Remedy of PTSD

Health

FDA Panel Weights MDMA Remedy for PTSD